Cardioprotective effects of hydrogen sulfide

Nitric Oxide - Biology and Chemistry

Volumn 25, Issue 2, 2011, Pages 201-210

  Szabó, Gábor ^a,b   Veres, Gábor ^a,b   Radovits, Tamás ^a,b   Ger, Domokos ^b,c   Módis, Katalin ^c   Miesel Gröschel, Christiane ^a   Horkay, Ferenc ^b   Karck, Matthias ^a   Szabó, Csaba ^c  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b SEMMELWEIS UNIVERSITY   (Hungary)

^c University of Texas Medical Branch School of Medicine   (United States)

Author keywords

Cardiac function; Cardiopulmonary bypass; Hydrogen sulfide; Ischemia reperfusion; Myocardial protection; Vascular reactivity

Indexed keywords

ACETYLCHOLINE; ADENOSINE TRIPHOSPHATE; HYDROGEN PEROXIDE; NITROPRUSSIDE SODIUM; SODIUM SULFIDE; TRANSCRIPTION FACTOR NRF2;

ANIMAL EXPERIMENT; ANIMAL MODEL; CARDIOPULMONARY BYPASS; CELL CULTURE; CONFERENCE PAPER; CONTROLLED STUDY; CORONARY BLOOD VESSEL; DOG; HEART ARREST; HEART FAILURE; HEART HEMODYNAMICS; HEART INJURY; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART PROTECTION; INDUCED HYPOTHERMIA; ISOLATED HEART; MITOCHONDRIAL RESPIRATION; NONHUMAN; PRIORITY JOURNAL; REOXYGENATION; REPERFUSION; VASODILATATION;

ACETYLCHOLINE; ANALYSIS OF VARIANCE; ANIMALS; BLOOD PRESSURE; CARDIOPULMONARY BYPASS; CARDIOTONIC AGENTS; CELL DEATH; CELL HYPOXIA; CELL LINE; CELL SURVIVAL; CORONARY VESSELS; DOGS; ENDOTHELIUM, VASCULAR; HEART; HYDROGEN SULFIDE; L-LACTATE DEHYDROGENASE; MODELS, ANIMAL; NITROPRUSSIDE; RATS; SULFIDES; VASODILATION; VASODILATOR AGENTS;

ANIMALIA; CANIS FAMILIARIS; RODENTIA;

EID: 80051545248     PISSN: 10898603     EISSN: 10898611     Source Type: Journal    
DOI: 10.1016/j.niox.2010.11.001     Document Type: Conference Paper

References (46)

1. H. Kimura Hydrogen sulfide: from brain to gut Antioxid. Redox Signal. 12 2010 1111 1123
2. C. Szabo Hydrogen sulphide and its therapeutic potential Nat. Rev. Drug Discov. 6 2007 917 935 (Pubitemid 350042399)
3. R. Wang The gasotransmitter role of hydrogen sulfide Antioxid. Redox Signal. 5 2003 493 501 (Pubitemid 37087410)
4. J.S. Bian, Q.C. Yong, T.T. Pan, Z.N. Feng, M.Y. Ali, S. Zhou, and P.K. Moore Role of hydrogen sulfide in the cardioprotection caused by ischemic preconditioning in the rat heart and cardiac myocytes J. Pharmacol. Exp. Ther. 316 2006 670 678 (Pubitemid 43130994)
5. J.W. Elrod, J.W. Calvert, J. Morrison, J.E. Doeller, D.W. Kraus, L. Tao, X. Jiao, R. Scalia, L. Kiss, C. Szabo, H. Kimura, C.W. Chow, and D.J. Lefer Hydrogen sulfide attenuates myocardial ischemia-reperfusion injury by preservation of mitochondrial function Proc. Natl. Acad. Sci. USA 104 2007 15560 15565 (Pubitemid 47502956)
6. L.F. Hu, T.T. Pan, K.L. Neo, Q.C. Yong, and J.S. Bian Cyclooxygenase-2 mediates the delayed cardioprotection induced by hydrogen sulfide preconditioning in isolated rat cardiomyocytes Pflugers Arch. 455 2008 971 978 (Pubitemid 351169971)
7. Y. Hu, X. Chen, T.T. Pan, K.L. Neo, S.W. Lee, E.S. Khin, P.K. Moore, and J.S. Bian Cardioprotection induced by hydrogen sulfide preconditioning involves activation of ERK and PI3K/Akt pathways Pflugers Arch. 455 2008 607 616 (Pubitemid 350160475)
8. T.T. Pan, Z.N. Feng, S.W. Lee, P.K. Moore, and J.S. Bian Endogenous hydrogen sulfide contributes to the cardioprotection by metabolic inhibition preconditioning in the rat ventricular myocytes J. Mol. Cell. Cardiol. 40 2006 119 130 (Pubitemid 43012123)
9. 2S preconditioning-induced PKC activation regulates intracellular calcium handling in rat cardiomyocytes Am. J. Physiol. Cell Physiol. 294 2008 C169 C177
10. S. Shi, Q.S. Li, H. Li, L. Zhang, M. Xu, J.L. Cheng, C.H. Peng, C.Q. Xu, and Y. Tian Anti-apoptotic action of hydrogen sulfide is associated with early JNK inhibition Cell Biol. Int. 33 2009 1095 1101
11. H. Wei, R. Zhang, H. Jin, D. Liu, X. Tang, C. Tang, and J. Du Hydrogen sulfide attenuates hyperhomocysteinemia-induced cardiomyocytic endoplasmic reticulum stress in rats Antioxid. Redox Signal. 12 2010 1079 1091
12. L.L. Yao, X.W. Huang, Y.G. Wang, Y.X. Cao, C.C. Zhang, and Y.C. Zhu Hydrogen sulfide protects cardiomyocytes from hypoxia/reoxygenation-induced apoptosis by preventing GSK-3beta-dependent opening of mPTP Am. J. Physiol. Heart Circ. Physiol. 298 2010 H1310 H1319
13. M. Bliksoen, M.L. Kaljusto, J. Vaage, and K.O. Stenslokken Effects of hydrogen sulphide on ischaemia-reperfusion injury and ischaemic preconditioning in the isolated, perfused rat heart Eur. J. Cardiothorac. Surg. 34 2008 344 349
14. X. Hu, T. Li, S. Bi, Z. Jin, G. Zhou, C. Bai, L. Li, Q. Cui, and W. Liu Possible role of hydrogen sulfide on the preservation of donor rat hearts Transplant. Proc. 39 2007 3024 3029 (Pubitemid 350251487)
15. Y. Ji, Q.F. Pang, G. Xu, L. Wang, J.K. Wang, and Y.M. Zeng Exogenous hydrogen sulfide postconditioning protects isolated rat hearts against ischemia-reperfusion injury Eur. J. Pharmacol. 587 2008 1 7
16. 2S) protects against regional myocardial ischemia-reperfusion injury - evidence for a role of K ATP channels Basic Res. Cardiol. 101 2006 53 60 (Pubitemid 43323432)
17. S. Minamishima, M. Bougaki, P.Y. Sips, J.D. Yu, Y.A. Minamishima, J.W. Elrod, D.J. Lefer, K.D. Bloch, and F. Ichinose Hydrogen sulfide improves survival after cardiac arrest and cardiopulmonary resuscitation via a nitric oxide synthase 3-dependent mechanism in mice Circulation 120 2009 888 896
18. Z. Zhang, H. Huang, P. Liu, C. Tang, and J. Wang Hydrogen sulfide contributes to cardioprotection during ischemia-reperfusion injury by opening K ATP channels Can. J. Physiol. Pharmacol. 85 2007 1248 1253 (Pubitemid 351196401)
19. J.W. Calvert, M. Elston, C.K. Nicholson, S. Gundewar, S. Jha, J.W. Elrod, A. Ramachandran, and D.J. Lefer Genetic and pharmacologic hydrogen sulfide therapy attenuates ischemia-induced heart failure in mice Circulation 122 2010 11 19
20. J.W. Calvert, S. Jha, S. Gundewar, J.W. Elrod, A. Ramachandran, C.B. Pattillo, C.G. Kevil, and D.J. Lefer Hydrogen sulfide mediates cardioprotection through Nrf2 signaling Circ. Res. 105 2009 365 374
21. S.C. Chuah, P.K. Moore, and Y.Z. Zhu S-Allylcysteine mediates cardioprotection in an acute myocardial infarction rat model via a hydrogen sulfide-mediated pathway Am. J. Physiol. Heart Circ. Physiol. 293 2007 H2693 H2701
22. B. Geng, L. Chang, C. Pan, Y. Qi, J. Zhao, Y. Pang, J. Du, and C. Tang Endogenous hydrogen sulfide regulation of myocardial injury induced by isoproterenol Biochem. Biophys. Res. Commun. 318 2004 756 763 (Pubitemid 38624219)
23. 2S ameliorates oxidative and proteolytic stresses and protects the heart against adverse remodeling in chronic heart failure Am. J. Physiol. Heart Circ. Physiol. 298 2010 H451 H456
24. A. Sivarajah, M. Collino, M. Yasin, E. Benetti, M. Gallicchio, E. Mazzon, S. Cuzzocrea, R. Fantozzi, and C. Thiemermann Anti-apoptotic and anti-inflammatory effects of hydrogen sulfide in a rat model of regional myocardial I/R Shock 31 2009 267 274
25. A. Sivarajah, M.C. McDonald, and C. Thiemermann The production of hydrogen sulfide limits myocardial ischemia and reperfusion injury and contributes to the cardioprotective effects of preconditioning with endotoxin, but not ischemia in the rat Shock 26 2006 154 161 (Pubitemid 44162501)
26. Y.W. Su, C. Liang, H.F. Jin, X.Y. Tang, W. Han, L.J. Chai, C.Y. Zhang, B. Geng, C.S. Tang, and J.B. Du Hydrogen sulfide regulates cardiac function and structure in adriamycin-induced cardiomyopathy Circ. J. 73 2009 741 749
27. Q. Wang, X.L. Wang, H.R. Liu, P. Rose, and Y.Z. Zhu Protective effects of cysteine analogues on acute myocardial ischemia: novel modulators of endogenous H(2)S production Antioxid. Redox Signal. 12 2010 1155 1165
28. X. Wang, Q. Wang, W. Guo, Y.Z. Zhu, Hydrogen sulfide attenuates cardiac dysfunction in a rat model of heart failure: a mechanism through cardiac mitochondrial protection, Biosci. Rep. (2010).
29. Y.Z. Zhu, Z.J. Wang, P. Ho, Y.Y. Loke, Y.C. Zhu, S.H. Huang, C.S. Tan, M. Whiteman, J. Lu, and P.K. Moore Hydrogen sulfide and its possible roles in myocardial ischemia in experimental rats J. Appl. Physiol. 102 2007 261 268 (Pubitemid 46089775)
30. Y. Zhuo, P.F. Chen, A.Z. Zhang, H. Zhong, C.Q. Chen, and Y.Z. Zhu Cardioprotective effect of hydrogen sulfide in ischemic reperfusion experimental rats and its influence on expression of survivin gene Biol. Pharm. Bull. 32 2009 1406 1410
31. R.M. Osipov, M.P. Robich, J. Feng, Y. Liu, R.T. Clements, H.P. Glazer, N.R. Sodha, C. Szabo, C. Bianchi, and F.W. Sellke Effect of hydrogen sulfide in a porcine model of myocardial ischemia-reperfusion: comparison of different administration regimens and characterization of the cellular mechanisms of protection J. Cardiovasc. Pharmacol. 54 2009 287 297
32. N.R. Sodha, R.T. Clements, J. Feng, Y. Liu, C. Bianchi, E.M. Horvath, C. Szabo, and F.W. Sellke The effects of therapeutic sulfide on myocardial apoptosis in response to ischemia-reperfusion injury Eur. J. Cardiothorac. Surg. 33 2008 906 913
33. N.R. Sodha, R.T. Clements, J. Feng, Y. Liu, C. Bianchi, E.M. Horvath, C. Szabo, G.L. Stahl, and F.W. Sellke Hydrogen sulfide therapy attenuates the inflammatory response in a porcine model of myocardial ischemia/reperfusion injury J. Thorac. Cardiovasc. Surg. 138 2009 977 984
34. R.M. Osipov, M.P. Robich, J. Feng, V. Chan, R.T. Clements, R.J. Deyo, C. Szabo, and F.W. Sellke Effect of hydrogen sulfide on myocardial protection in the setting of cardioplegia and cardiopulmonary bypass Interact. Cardiovasc. Thorac. Surg. 10 2010 506 512
35. Q.C. Yong, S.W. Lee, C.S. Foo, K.L. Neo, X. Chen, and J.S. Bian Endogenous hydrogen sulphide mediates the cardioprotection induced by ischemic postconditioning Am. J. Physiol. Heart Circ. Physiol. 295 2008 H1330 H1340
36. A. Wallace, H.W. Lam, P.S. Nose, W. Bellows, and D.T. Mangano Changes in systolic and diastolic ventricular function with cold cardioplegic arrest in man. The Multicenter Study of Perioperative Ischemia (McSPI) Research Group J. Card. Surg. 9 1994 497 502 (Pubitemid 24171192)
37. J. Gorcsan 3rd, T.A. Gasior, W.A. Mandarino, L.G. Deneault, B.G. Hattler, and M.R. Pinsky Assessment of the immediate effects of cardiopulmonary bypass on left ventricular performance by on-line pressure-area relations Circulation 89 1994 180 190 (Pubitemid 24026488)
38. F.W. Sellke, T. Shafique, D.L. Ely, and R.M. Weintraub Coronary endothelial injury after cardiopulmonary bypass and ischemic cardioplegia is mediated by oxygen-derived free radicals Circulation 88 1993 II395 II400
39. G. Szabo, P. Soos, S. Mandera, U. Heger, C. Flechtenmacher, L. Seres, Z. Zsengeller, F.U. Sack, C. Szabo, and S. Hagl Mesenteric injury after cardiopulmonary bypass: role of poly(adenosine 5′-diphosphate-ribose) polymerase Crit. Care Med. 32 2004 2392 2397 (Pubitemid 39648218)
40. T. Radovits, S. Korkmaz, C. Miesel-Groschel, B. Seidel, J.P. Stasch, B. Merkely, M. Karck, G. Szabo, Pre-conditioning with the soluble guanylate cyclase activator Cinaciguat reduces ischaemia-reperfusion injury after cardiopulmonary bypass, Eur. J. Cardiothorac. Surg. (2010).
41. G. Szabo, T. Radovits, G. Veres, N. Krieger, S. Loganathan, P. Sandner, and M. Karck Vardenafil protects against myocardial and endothelial injuries after cardiopulmonary bypass Eur. J. Cardiothorac. Surg. 36 2009 657 664
42. G. Veres, T. Radovits, G. Otila, K. Hirschberg, H. Haider, N. Krieger, A. Knoll, E. Weigang, Z. Szabolcs, M. Karck, and G. Szabo Efficacy of the non-adenosine analogue A1 adenosine receptor agonist (BR-4935) on cardiovascular function after cardiopulmonary bypass Thorac. Cardiovasc. Surg. 58 2010 86 92
43. K. Módis, D. Gero, N. Nagy, P. Szoleczky, Z.D. Tóth, and C. Szabó Cytoprotective effects of adenosine and inosine in an in vitro model of acute tubular necrosis Br. J. Pharmacol. 158 2009 1565 1578
44. R.C. Zanardo, V. Brancaleone, E. Distrutti, S. Fiorucci, G. Cirino, and J.L. Wallace Hydrogen sulfide is an endogenous modulator of leukocyte-mediated inflammation FASEB J. 20 2006 2118 2120
45. L.F. Hu, P.T. Wong, P.K. Moore, and J.S. Bian Hydrogen sulfide attenuates lipopolysaccharide-induced inflammation by inhibition of p38 mitogen-activated protein kinase in microglia J. Neurochem. 100 2007 1121 1128 (Pubitemid 46213934)
46. M. Bucci, A. Papapetropoulos, V. Vellecco, Z. Zhou, A. Pyriochou, C. Roussos, F. Roviezzo, V. Brancaleone, and G. Cirino Hydrogen sulfide is an endogenous inhibitor of phosphodiesterase activity Arterioscler. Thromb. Vasc. Biol. 30 2010 1998 2004